Examining Resources, Initiatives, and Regulatory Pathways to Advance Regenerative Medicine Manufacturing
Joshua Hunsberger, Martha Lundberg, Julie Allickson, Claudia Zylberberg, Sarah Beachy, Carl Simon Jr.
This perspective article is inspired by a workshop entitled "Cell and Tissue Manufacturing Innovation" that was held at the Tissue Engineering and Regenerative medicine Society (TERMIS). Five main concepts are discussed: 1) the US National Academies' Forum on Regenerative Medicine, 2) academic translational programs, 3) developing measurements for regenerative medicine, 4) developing standards for ancillary materials and 5) the global landscape for accelerating regenerative medicine manufacturing. Concepts are presented with current perspective and key insights on challenges, opportunities and next steps for cell and tissue manufacturing innovation.
, Lundberg, M.
, Allickson, J.
, Zylberberg, C.
, Beachy, S.
and Simon Jr., C.
Examining Resources, Initiatives, and Regulatory Pathways to Advance Regenerative Medicine Manufacturing, Cytotherapy, [online], https://doi.org/10.1007/s40778-019-00163-0
(Accessed December 3, 2023)